Monotherapy and Combination Therapy Using Anti‐Angiogenic Nanoagents to Fight Cancer

Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer

(2020) Anubhab Mukherjee et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments

(2020) Paz de la Torre et al.   MOLECULES

Targeted drugs ramp up cancer mutability

(2020) Marco Gerlinger   SCIENCE

Meet Our Editorial Board Member

(2020) Douglas A. Kinghorn   Anti-Cancer Agents in Medicinal Chemistry

A self-assembling peptide targeting VEGF receptors to inhibit angiogenesis

(2020) Shifang Wen et al.   CHINESE CHEMICAL LETTERS

Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity

(2020) Won Suk Lee et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Oligo Hyaluronan‐Coated Silica/Hydroxyapatite Degradable Nanoparticles for Targeted Cancer Treatment

(2019) Yao Kang et al.   Advanced Science

Gold Nanoparticles for Photothermal Cancer Therapy

(2019) Jeremy B. Vines et al.   Frontiers in Chemistry

A pH-responsive zinc (II) metalated porphyrin for enhanced photodynamic/photothermal combined cancer therapy

(2019) Pingping Liang et al.   Science China-Materials

Cancer treatment and survivorship statistics, 2019

(2019) Kimberly D. Miller et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Antiangiogenic properties of nanoparticles: a systematic review

(2019) Brhaish Ali Saeed et al.   International Journal of Nanomedicine

Polyethylenimine-coated superparamagnetic iron oxide nanoparticles impair in vitro and in vivo angiogenesis

(2019) Vladimir Mulens-Arias et al.   Nanomedicine-Nanotechnology Biology and Medicine

The emergence of drug resistance to targeted therapies: Clinical evidence

(2019) Ana Bela Sarmento-Ribeiro et al.   DRUG RESISTANCE UPDATES

Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications

(2019) Ruba S. Darweesh et al.   International Journal of Nanomedicine

Responsively Aggregatable Sub-6 nm Nanochelators Induce Simultaneous Antiangiogenesis and Vascular Obstruction for Enhanced Tumor Vasculature Targeted Therapy

(2019) Yannan Yang et al.   NANO LETTERS

A view on drug resistance in cancer

(2019) Neil Vasan et al.   NATURE

Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumours

(2018) Qin Dai et al.   ACS Nano

Emerging Strategies of Cancer Therapy Based on Ferroptosis

(2018) Zheyu Shen et al.   ADVANCED MATERIALS

A Magnetofluorescent Carbon Dot Assembly as an Acidic H2 O2 -Driven Oxygenerator to Regulate Tumor Hypoxia for Simultaneous Bimodal Imaging and Enhanced Photodynamic Therapy

(2018) Qingyan Jia et al.   ADVANCED MATERIALS

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma

(2018) Cherine Abou Faycal et al.   BRITISH JOURNAL OF CANCER

Challenges and opportunities of using stereotactic body radiotherapy with anti-angiogenesis agents in tumor therapy

(2018) Xiaowen Sun et al.   Chinese Journal of Cancer Research

Biogenic synthesis, characterization, acute oral toxicity studies of synthesized Ag and ZnO nanoparticles using aqueous extract of Lawsonia inermis

(2018) N. Jayarambabu et al.   MATERIALS LETTERS

Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy

(2018) Xue Yang et al.   Nanomedicine-Nanotechnology Biology and Medicine

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

(2018) Dai Fukumura et al.   Nature Reviews Clinical Oncology

Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa

(2018) Kabir A. Khan et al.   Nature Reviews Clinical Oncology

Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer

(2018) Cheng-Liang Peng et al.   Photodiagnosis and Photodynamic Therapy

Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors

(2018) Ryszard Smolarczyk et al.   Scientific Reports

Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics

(2018) Ahmed M.E. Abdalla et al.   Theranostics

Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer

(2018) Yijing Liu et al.   CHEMICAL SOCIETY REVIEWS

Green synthesis of silver nanoparticles using Trapa natans extract and their anticancer activity against A431 human skin cancer cells

(2018) Mohaddeseh Mahmoudi Saber et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Tumor-Microenvironment-Responsive Nanoconjugate for Synergistic Antivascular Activity and Phototherapy

(2018) Pingping Liang et al.   ACS Nano

A Water-Soluble, NIR-Absorbing Quaterrylenediimide Chromophore for Photoacoustic Imaging and Efficient Photothermal Cancer Therapy

(2018) Chang Liu et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer

(2018) Gal Shafirstein et al.   BRITISH JOURNAL OF CANCER

Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities

(2018) Fatemeh Farjadian et al.   Nanomedicine

Nanoparticles and targeted drug delivery in cancer therapy

(2017) Behdokht Bahrami et al.   IMMUNOLOGY LETTERS

Tumor vascular infarction: prospects and challenges

(2017) Rana Jahanban-Esfahlan et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Combination of nanotechnology with vascular targeting agents for effective cancer therapy

(2017) Rana Jahanban-Esfahlan et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Modulating tumor hypoxia by nanomedicine for effective cancer therapy

(2017) Rana Jahanban-Esfahlan et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Nanoparticles as new tools for inhibition of cancer angiogenesis

(2017) Nasser Hashemi Goradel et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach

(2017) Hyo Sung Jung et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC

(2017) Christian Manegold et al.   Journal of Thoracic Oncology

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

(2017) Abdel-Rahmène Azzouzi et al.   LANCET ONCOLOGY

Fabrication of metalosomes (metal containing cationic liposomes) using single chain surfactants as a precursor via formation of inorganic organic hybrids

(2017) Preeti Garg et al.   PHYSICAL CHEMISTRY CHEMICAL PHYSICS

Tumor-targeting templated silica nanoparticles as a dual-drug delivery system for anti-angiogenic ovarian cancer therapy

(2017) Tianying Zheng et al.   Experimental and Therapeutic Medicine

Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites

(2017) Hong Yang et al.   Biomaterials Science

A non-cytotoxic dendrimer with innate and potent anticancer and anti-metastatic activities

(2017) Shiqun Shao et al.   Nature Biomedical Engineering

A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins

(2017) Tobias G. Kapp et al.   Scientific Reports

Superparamagnetic Iron Oxide Nanoparticles Modified with Tween 80 Pass through the Intact Blood–Brain Barrier in Rats under Magnetic Field

(2016) Yinping Huang et al.   ACS Applied Materials & Interfaces

Massive Intracellular Biodegradation of Iron Oxide Nanoparticles Evidenced Magnetically at Single-Endosome and Tissue Levels

(2016) François Mazuel et al.   ACS Nano

Enhanced Nanodrug Delivery to Solid Tumors Based on a Tumor Vasculature-Targeted Strategy

(2016) Chenghua Song et al.   ADVANCED FUNCTIONAL MATERIALS

Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy

(2016) Chenggen Qian et al.   ADVANCED MATERIALS

Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor

(2016) Hua Jin et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application

(2016) Pei-Xin Lai et al.   BIOMATERIALS

Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer

(2016) Miriana Hijaz et al.   BMC CANCER

Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance

(2016) H. Naito et al.   CANCER RESEARCH

Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasivenessviaEGFR/VEGFR-2-mediated pathway in breast cancer

(2016) S. Balakrishnan et al.   CELL PROLIFERATION

Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma

(2016) Anusha Kalbasi et al.   CLINICAL CANCER RESEARCH

Perspectives for vanadium in health issues

(2016) Dieter Rehder   Future Medicinal Chemistry

Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches

(2016) Xi-Feng Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles

(2016) Nardine S. Abadeer et al.   Journal of Physical Chemistry C

Antiangiogenic therapy in oncology: current status and future directions

(2016) Gordon C Jayson et al.   LANCET

RGD peptide-conjugated selenium nanoparticles: antiangiogenesis by suppressing VEGF-VEGFR2-ERK/AKT pathway

(2016) Xiaoyan Fu et al.   Nanomedicine-Nanotechnology Biology and Medicine

Therapeutic application of anti-angiogenic nanomaterials in cancers

(2016) Sudip Mukherjee et al.   Nanoscale

Ten years of anti-vascular endothelial growth factor therapy

(2016) Napoleone Ferrara et al.   NATURE REVIEWS DRUG DISCOVERY

Actions of l -thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells

(2016) Hung-Yun Lin et al.   STEROIDS

Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma

(2016) Kulthida Vaeteewoottacharn et al.   TUMOR BIOLOGY

A self-reporting AIE probe with a built-in singlet oxygen sensor for targeted photodynamic ablation of cancer cells

(2016) Youyong Yuan et al.   Chemical Science

Gold Nanoparticle–Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy

(2016) Wei Li et al.   Scientific Reports

Recent Developments of Liposomes as Nanocarriers for Theranostic Applications

(2016) Hang Xing et al.   Theranostics

Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery

(2016) Domenico Lombardo et al.   Nanomaterials

Laser-Triggered Small Interfering RNA Releasing Gold Nanoshells against Heat Shock Protein for Sensitized Photothermal Therapy

(2016) Zhaohui Wang et al.   Advanced Science

Analysis of nanoparticle delivery to tumours

(2016) Stefan Wilhelm et al.   Nature Reviews Materials

Opening Windows into Tumors

(2015) Dmitri Simberg   ACS Nano

Tumor Microenvironment Activated Photothermal Strategy for Precisely Controlled Ablation of Solid Tumors upon NIR Irradiation

(2015) Enguo Ju et al.   ADVANCED FUNCTIONAL MATERIALS

Two-Dimensional Nanomaterials for Biomedical Applications: Emerging Trends and Future Prospects

(2015) David Chimene et al.   ADVANCED MATERIALS

Selenium compounds as therapeutic agents in cancer

(2015) Aristi P. Fernandes et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo

(2015) Sixiang Shi et al.   BIOMATERIALS

Radiation-/hypoxia-induced solid tumor metastasis and regrowth inhibited by hypoxia-specific upconversion nanoradiosensitizer

(2015) Yanyan Liu et al.   BIOMATERIALS

Biomedical Applications of Gold Nanoparticles

(2015) Daniela Cabuzu et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Silver nanoparticles: synthesis, properties, and therapeutic applications

(2015) Liuya Wei et al.   DRUG DISCOVERY TODAY

Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies

(2015) Hannelore Maes et al.   FEBS Journal

Targeting autophagy to overcome drug resistance in cancer therapy

(2015) Ankit Kumar et al.   Future Medicinal Chemistry

Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a Glimpse

(2015) Sarah E. Church et al.   IMMUNITY

Remote control of the permeability of the blood–brain barrier by magnetic heating of nanoparticles: A proof of concept for brain drug delivery

(2015) Seyed Nasrollah Tabatabaei et al.   JOURNAL OF CONTROLLED RELEASE

H2O2-Activatable and O2-Evolving Nanoparticles for Highly Efficient and Selective Photodynamic Therapy against Hypoxic Tumor Cells

(2015) Huachao Chen et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Targeting copper in cancer therapy: ‘Copper That Cancer’

(2015) Delphine Denoyer et al.   Metallomics

Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer

(2015) Rebecca S. Heist et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ανβ3-targeted Copper Nanoparticles Incorporating an Sn 2 Lipase-Labile Fumagillin Prodrug for Photoacoustic Neovascular Imaging and Treatment

(2015) Ruiying Zhang et al.   Theranostics

Nanoparticles for inhibition of in vitro tumour angiogenesis: synergistic actions of ligand function and laser irradiation

(2015) Dorota Bartczak et al.   Biomaterials Science

pH-Dependent Activity of Dextran-Coated Cerium Oxide Nanoparticles on Prohibiting Osteosarcoma Cell Proliferation

(2015) Ece Alpaslan et al.   ACS Biomaterials-Science & Engineering

pH-Dependent Activity of Dextran-Coated Cerium Oxide Nanoparticles on Prohibiting Osteosarcoma Cell Proliferation

(2015) Ece Alpaslan et al.   ACS Biomaterials Science & Engineering

PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy

(2014) Guangzhi Gu et al.   BIOMATERIALS

Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer

(2014) Robert C. Doebele et al.   CANCER

Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia

(2014) Rakesh K. Jain   CANCER CELL

Pharmacokinetics of single-agent axitinib across multiple solid tumor types

(2014) Michael A. Tortorici et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity

(2014) Daniela Guarnieri et al.   JOURNAL OF NANOPARTICLE RESEARCH

Promising Early Results for Immunotherapy-Antiangiogenesis Combination

(2014) K. Garber   JNCI-Journal of the National Cancer Institute

A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer

(2014) D. Ross Camidge et al.   Journal of Thoracic Oncology

Anti-Angiogenesis Effect of Biogenic Silver Nanoparticles Synthesized Using Saliva officinalis on Chick Chorioalantoic Membrane (CAM)

(2014) Javad Baharara et al.   MOLECULES

Therapeutic potential of nanoceria in regenerative medicine

(2014) Soumen Das et al.   MRS BULLETIN

The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging

(2014) Qianqian Yu et al.   Nanoscale

Anti-Angiogenesis Therapy in the Vx2 Rabbit Cancer Model with a Lipase-cleavable Sn 2 Taxane Phospholipid Prodrug using αvβ3-Targeted Theranostic Nanoparticles

(2014) Dipanjan Pan et al.   Theranostics

Potential Theranostics Application of Bio-Synthesized Silver Nanoparticles (4-in-1 System)

(2014) Sudip Mukherjee et al.   Theranostics

Manipulation of in Vitro Angiogenesis Using Peptide-Coated Gold Nanoparticles

(2013) Dorota Bartczak et al.   ACS Nano

Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer

(2013) C. Twelves et al.   ANNALS OF ONCOLOGY

Anti-angiogenic activity of heparin functionalised cerium oxide nanoparticles

(2013) Megan S. Lord et al.   BIOMATERIALS

Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles

(2013) Dongdong Sun et al.   BIOMATERIALS

Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales

(2013) Asmaa E El-Kenawi et al.   BRITISH JOURNAL OF PHARMACOLOGY

The chemistry of functional nanomaterials

(2013) Yadong Yin et al.   CHEMICAL SOCIETY REVIEWS

Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease

(2013) Claire M. Weekley et al.   CHEMICAL SOCIETY REVIEWS

The future of/for vanadium

(2013) Dieter Rehder   DALTON TRANSACTIONS

Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers

(2013) Rakesh K. Jain   JOURNAL OF CLINICAL ONCOLOGY

Investigation of the Therapeutic Efficacy of Codelivery of psiRNA–Vascular Endothelial Growth Factor and pIL-4 into Chitosan Nanoparticles in the Breast Tumor Model

(2013) Emine Şalva et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Cerium oxide nanoparticles: applications and prospects in nanomedicine

(2013) Soumen Das et al.   Nanomedicine

Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer

(2013) Dhruba J Bharali et al.   Nanomedicine

Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression

(2013) Hongyuan Song et al.   Nanoscale

Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer

(2013) Shailendra Giri et al.   PLoS One

Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle

(2013) R. R. Arvizo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ablative Hypofractionated Radiotherapy Normalizes Tumor Vasculature in Lewis Lung Carcinoma Mice Model

(2013) Jie Lan et al.   RADIATION RESEARCH

Antiangiogenic Therapies: Going beyond Their Limits

(2013) L. Moserle et al.   Cancer Discovery

The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling

(2012) Dongdong Sun et al.   BIOMATERIALS

Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future

(2012) Rochelle R. Arvizo et al.   CHEMICAL SOCIETY REVIEWS

Copper levels in patients with hematological malignancies

(2012) Georgia D. Kaiafa et al.   European Journal of Internal Medicine

Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses

(2012) Neelam Azad et al.   Nanotoxicology

A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model

(2011) Xu Wang et al.   ACS Nano

Gold nanoparticles in biomedical applications: recent advances and perspectives

(2011) Lev Dykman et al.   CHEMICAL SOCIETY REVIEWS

Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration

(2011) Marwan Abouammoh et al.   CURRENT OPINION IN OPHTHALMOLOGY

Vatalanib in Advanced Colorectal Cancer: Two Studies With Identical Results

(2011) Alberto F. Sobrero et al.   JOURNAL OF CLINICAL ONCOLOGY

Compact Zwitterion-Coated Iron Oxide Nanoparticles for Biological Applications

(2011) He Wei et al.   NANO LETTERS

Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge

(2011) Rochelle R. Arvizo et al.   Nanomedicine-Nanotechnology Biology and Medicine

Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor

(2011) Dong Hyun Jo et al.   Nanomedicine-Nanotechnology Biology and Medicine

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition

(2011) P. M. Krawczyk et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Basic Science Research in Thermal Ablation

(2011) Muneeb Ahmed et al.   Surgical Oncology Clinics of North America

Shape Effect of Carbon Nanovectors on Angiogenesis

(2010) Padmaparna Chaudhuri et al.   ACS Nano

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

(2010) M. Reck et al.   ANNALS OF ONCOLOGY

The role of porphyrin chemistry in tumor imaging and photodynamic therapy

(2010) Manivannan Ethirajan et al.   CHEMICAL SOCIETY REVIEWS

Vessel abnormalization: another hallmark of cancer?Molecular mechanisms and therapeutic implications

(2010) Katrien De Bock et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Angiogenesis inhibitors in the treatment of prostate cancer

(2010) Clara Hwang et al.   Journal of Hematology & Oncology

Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer

(2010) Alan Sandler et al.   Journal of Thoracic Oncology

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

(2010) Lucio Crinò et al.   LANCET ONCOLOGY

A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies

(2010) Laura C. Kennedy et al.   Small

Antiangiogenic properties of silver nanoparticles

(2009) Sangiliyandi Gurunathan et al.   BIOMATERIALS

Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity

(2009) Elodie Boisselier et al.   CHEMICAL SOCIETY REVIEWS

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

(2009) Martin Reck et al.   JOURNAL OF CLINICAL ONCOLOGY

Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles

(2009) Hae Yun Nam et al.   JOURNAL OF CONTROLLED RELEASE

Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells

(2009) Nathan P. Gabrielson et al.   JOURNAL OF CONTROLLED RELEASE

Synthesis and Surface Modification of Highly Monodispersed, Spherical Gold Nanoparticles of 50−200 nm

(2009) Steven D. Perrault et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties

(2009) Melissa M Kemp et al.   NANOTECHNOLOGY

Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis

(2009) Shelton D. Caruthers et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Elevated copper and oxidative stress in cancer cells as a target for cancer treatment

(2008) Anshul Gupte et al.   CANCER TREATMENT REVIEWS

Novel anti-angiogenic therapies for malignant gliomas

(2008) Andrew D Norden et al.   LANCET NEUROLOGY